CARMA3 is overexpressed in colon cancer and regulates NF-κB activity and cyclin D1 expression

Biochemical and Biophysical Research Communications

Volumn 425, Issue 4, 2012, Pages 781-787

  Miao, Zhifeng ^a   Zhao, Tingting ^a   Wang, Zhenning ^a   Xu, Yingying ^a   Song, Yongxi ^a   Wu, Jianhua ^a   Xu, Huimian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

CARMA3; Cyclin D1; NF B; Proliferation

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; CYCLIN D1; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KI 67 ANTIGEN; PROTEIN CARMA3; RETINOBLASTOMA PROTEIN; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CELL CYCLE CHECKPOINT; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION;

CARD SIGNALING ADAPTOR PROTEINS; COLONIC NEOPLASMS; CYCLIN D1; FEMALE; GENE KNOCKDOWN TECHNIQUES; HCT116 CELLS; HT29 CELLS; HUMANS; MALE; MIDDLE AGED; NF-KAPPA B; NITRILES; RNA, SMALL INTERFERING; SULFONES;

EID: 84865996948     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.07.152     Document Type: Article

References (19)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics. CA Cancer J. Clin. 2012, 62(1):10-29.
2. Wang L., Guo Y., Huang W.J., Ke X., Poyet J.L., Manji G.A., Merriam S., Glucksmann M.A., DiStefano P.S., Alnemri E.S., Bertin J. Card10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B. J. Biol. Chem. 2001, 276(24):21405-21409.
3. McAllister-Lucas L.M., Inohara N., Lucas P.C., Ruland J., Benito A., Li Q., Chen S., Chen F.F., Yamaoka S., Verma I.M., Mak T.W., Nunez G. Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction. J. Biol. Chem. 2001, 276(33):30589-30597.
4. Grabiner B.C., Blonska M., Lin P.C., You Y., Wang D., Sun J., Darnay B.G., Dong C., Lin X. CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation. Genes Dev. 2007, 21(8):984-996.
5. McAllister-Lucas L.M., Ruland J., Siu K., Jin X., Gu S., Kim D.S., Kuffa P., Kohrt D., Mak T.W., Nunez G., Lucas P.C. CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells. Proc. Natl. Acad. Sci. U S A 2007, 104(1):139-144.
6. Aggarwal B.B. Nuclear factor-kappaB: the enemy within. Cancer Cell 2004, 6(3):203-208.
7. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004, 18(18):2195-2224.
8. Mahanivong C., Chen H.M., Yee S.W., Pan Z.K., Dong Z., Huang S. Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells. Oncogene 2008, 27(9):1273-1280.
9. Rehman A.O., Wang C.Y. CXCL12/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex. Int. J. Oral Sci. 2009, 1(3):105-118.
10. Allegra C.J., Paik S., Colangelo L.H., Parr A.L., Kirsch I., Kim G., Klein P., Johnston P.G., Wolmark N., Wieand H.S. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a national cancer institute-national surgical adjuvant breast and bowel project collaborative study. J. Clin. Oncol. 2003, 21(2):241-250.
11. G. He, G.Y. Yu, V. Temkin, H. Ogata, C. Kuntzen, T. Sakurai, W. Sieghart, M. Peck-Radosavljevic, H.L. Leffert, and M. Karin, Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell. 17 (3) (2010) 286-97.
12. Umar S., Sarkar S., Cowey S., Singh P. Activation of NF-kappaB is required for mediating proliferative and antiapoptotic effects of progastrin on proximal colonic crypts of mice, in vivo. Oncogene 2008, 27(42):5599-5611.
13. T. Jiang, B. Grabiner, Y. Zhu, C. Jiang, H. Li, Y. You, J. Lang, M.C. Hung, and X. Lin, CARMA3 is crucial for EGFR-Induced activation of NF-kappaB and tumor progression. Cancer Res. 71 (6) (2011) 2183-92.
14. Kim J.K., Diehl J.A. Nuclear cyclin D1: an oncogenic driver in human cancer. J. Cell Physiol. 2009, 220(2):292-296.
15. Knudsen K.E., Diehl J.A., Haiman C.A., Knudsen E.S. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 2006, 25(11):1620-1628.
16. J. Sun, CARMA3: A novel scaffold protein in regulation of NF-kappaB activation and diseases. World, J Biol Chem. 1 (12) (2010) 353-61.
17. L.M. McAllister-Lucas, X. Jin, S. Gu, K. Siu, S. McDonnell, J. Ruland, P.C. Delekta, M. Van Beek, and P.C. Lucas, The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis. J Biol Chem. 285 (34) (2010) 25880-4.
18. Park S.G., Chung C., Kang H., Kim J.Y., Jung G. Up-regulation of cyclin D1 by HBx is mediated by NF-kappaB2/BCL3 complex through kappaB site of cyclin D1 promoter. J. Biol. Chem. 2006, 281(42):31770-31777.
19. Ouyang W., Ma Q., Li J., Zhang D., Liu Z.G., Rustgi A.K., Huang C. Cyclin D1 induction through IkappaB kinase beta/nuclear factor-kappaB pathway is responsible for arsenite-induced increased cell cycle G1-S phase transition in human keratinocytes. Cancer Res. 2005, 65(20):9287-9293.